tradingkey.logo
tradingkey.logo
Search

Transmedics Group Inc

TMDX
Add to Watchlist
88.240USD
+19.260+27.92%
Close 11-06 16:00(ET)
3.06BMarket Cap
17.48P/E TTM
After-hours 18:56 (ET)87.700USD-0.530-0.60%

Today

+27.92%

5 Days

+33.72%

1 Month

+8.84%

6 Months

+21.04%

Year to Date

-27.46%

1 Year

-25.95%

Key Figures

79.115Open
88.430High
327.96KVolume
17.48P/E TTM
33.84P/E Dynamic
--Dividend TTM
0.95%Turnover Ratio
68.980Prev. Close
67.330Low
27.82MTurnover
86.28P/E Static
5.91P/B
0.00%Div Yield TTM
15.13%ROA
156.00052wk High
0.28Volume Ratio
35.46MNet Profit
34.68MShares
5.0490EPS TTM
1.94Beta
45.22%ROE
60.10552wk Low
30.59%Amplitude
58.74%Gross Margin
3.06BMarket Cap
6.47Reward/Risk
3.64%Risk Rate
Recent
Earnings
Transcripts
More news coming soon, stay tuned...

Transmedics Group Inc's Score

0.25vs previous score
Forecast7.69
Financial Health8.49
Technical5.45
Valuation Dimensions7.77
Institutional Confidence10.00
Risk Assessment5.53

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
103.455Target Price
+56.77%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy33333555
Buy55566666
Hold55544333
Sell00000000
Strong Sell00000000

Transmedics Group Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Neutral
Summary
Buy
Moving Average
Strong buy

Transmedics Group Inc Latest Earnings Call Transcripts

TransMedics (TMDX) Q3 2026 Earnings Call: Record Revenue and Higher Guidance

TransMedics Q3 2026 earnings call: revenue rose 41% to $203 million, margins improved excluding PAD, and 2026 guidance increased to $764 million–$774 million.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
0.49/0.29
Revenue / Forecast
203.00M/177.58M

Transmedics Group Inc Profile

SectorHealthcare Equipment & Supplies
Ticker SymbolTMDX
Number of employees728
CountryUnited States of America

Ownership

ShareholdersProportion
BlackRock Institutional Trust Company, N.A.13.92%
Fidelity Management & Research Company LLC12.93%
Vanguard Portfolio Management, LLC5.55%
Vanguard Capital Management, LLC4.28%
Shareholder TypesProportion
Investment Advisor73.74%
Investment Advisor/Hedge Fund24.06%
Hedge Fund5.98%
Research Firm4.71%

FAQs

What is the current price of Transmedics Group Inc (TMDX)?

The current price of Transmedics Group Inc (TMDX) is 88.24.

What is the symbol of Transmedics Group Inc?

The ticker symbol of Transmedics Group Inc is TMDX.

What is the 52-week high of Transmedics Group Inc?

The 52-week high of Transmedics Group Inc is 156.00.

What is the 52-week low of Transmedics Group Inc?

The 52-week low of Transmedics Group Inc is 60.10.

What is the market capitalization of Transmedics Group Inc?

The market capitalization of Transmedics Group Inc is 3.06B.

Is Transmedics Group Inc (TMDX) currently rated as Buy, Hold, or Sell?

According to analysts, Transmedics Group Inc (TMDX) has an overall rating of Buy, with a price target of 103.45.

What is the Earnings Per Share (EPS TTM) of Transmedics Group Inc (TMDX)?

The Earnings Per Share (EPS TTM) of Transmedics Group Inc (TMDX) is 5.05.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.